CLC bio achieves massive growth in 2009 and closes year with 7-figure deal
CLC bio announced that their financial year 2009 was closed with a 7-figure US Dollar deal involving a multinational corporation working extensively with high-throughput sequencing data analysis on multiple levels.
Vice President of Global Sales & Marketing at CLC bio, Jan Lomholdt, states, "I am satisfied with the fact that we have implemented a 3-tier Next Generation Sequencing data analysis platform in one of the worlds largest multinational biotechnology corporations. This shows that we are pushing the standards for any industry working with Next Generation Sequencing, and we look forward to announcing similar deals throughout 2010."
The agreement also means that CLC bio managed a year over year increase in sales of more than 130% during 2009 compared to 2008, whereas 2007 to 2008 resulted in an increase of 108%.
CEO at CLC bio, Thomas Knudsen, continues, "We're extremely proud of the triple digit growth we're announcing alongside this deal today - especially taking the worldwide economical situation into consideration. We experience accelerated global interest in our Next Generation Sequencing solutions - especially in our enterprise level solutions. Thus I expect a continued aggressive growth in CLC bio’s sales volume in 2010. "
CLC bio has started 2010 with opening new offices in Stockholm, Sweden and in Rotterdam, Netherlands. CLC bio now has offices in 9 countries around the globe to better serve customers in the pharmaceutical industry, agricultural biotechnology, human biotechnology, as well as government and academic research institutes.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Researchers 3D print components for a portable mass spectrometer - Lightweight and inexpensive, miniaturized mass filters are a key step toward portable mass spectrometers that could identify unknown chemicals in remote settings
New polymer mixture creates ultra-sensitive heat sensor - Polymer gels with tunable ionic Seebeck coefficient for ultra-sensitive printed thermopiles
First look at how our cells can 'swallow up and quarantine' Zika
Prion fingerprints detected with glowing molecule
Monitoring the corrosion of bioresorbable magnesium - Better prediction of degradation rate of magnesium implants
Unlike rubber bands, molecular bonds may not break faster when pulled
Machine learning reveals the mysteries of thin films at atomic scale - High-accuracy atomistic modeling of amorphous materials